Agomelatine in Depressive Disorders: Its Novel Mechanisms of Action
Disruptions in sleep and sleep–wake cycle regulation have been identified as one of the main causes for the pathophysiology of depressive disorders. The search has been on for the identification of an ideal antidepressant that could improve both sleep disturbances and depressive symptomatology...
Main Authors: | Srinivasan, Venkataramanujan, Zakaria, Rahimah, Othman, Zahiruddin, Lauterbach, Edward C., Acuña-Castroviejo, Darío |
---|---|
Format: | Article |
Language: | English |
Published: |
American Psychiatric Publishing
2012
|
Subjects: | |
Online Access: | http://eprints.usm.my/44437/1/2012_JNCN_-_Agomelatine_in_Depressive_Disorders.pdf |
Similar Items
-
The use of melatonin for treating sleep disorders in patients with Parkinson’s disease
by: Srinivasan, Venkataramanujam, et al.
Published: (2014) -
Melatonergic Drugs for Therapeutic Use in Insomnia and Sleep
Disturbances of Mood Disorders
by: Srinivasan, Venkatramanujam, et al.
Published: (2012) -
Melatonin, insomnia and the use of melatonergic drugs
by: Srinivasan, Venkatramanujam, et al.
Published: (2012) -
Preliminary Study: Effects of Social
Instability Stress on Depressive
Behaviours in Ovariectomised Rats
by: Al-Rahbi, Badriya, et al.
Published: (2013) -
The Potential Role of Melatonin on Memory Function:
Lessons from Rodent Studies
by: Zakaria, Rahimah, et al.
Published: (2016)